Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr119.50 SEK
Change Today +4.10 / 3.55%
Volume 763.8K
MEDAA On Other Exchanges
As of 11:29 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

meda ab-a shs (MEDAA) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - kr152.00
52 Week Low
10/16/14 - kr85.61
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDA AB-A SHS (MEDAA)

Related News

No related news articles were found.

meda ab-a shs (MEDAA) Related Businessweek News

No Related Businessweek News Found

meda ab-a shs (MEDAA) Details

Meda AB operates as a specialty pharmaceutical company worldwide. It manufactures and sells specialty pharmaceutical products, branded generics, over-the-counter drugs, and other products in various therapy areas, such as respiratory, dermatology, gastroenterology, cardiology, pain and inflammation, and CNS, as well as metabolism/vitamins. The company markets and sells its products through distributors in approximately 150 countries. Meda AB is headquartered in Solna, Sweden.

4,516 Employees
Last Reported Date: 04/8/15

meda ab-a shs (MEDAA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr17.0M
Compensation as of Fiscal Year 2014.

meda ab-a shs (MEDAA) Key Developments

Meda AB (publ) Declares Dividend

At the annual general meeting on May 6, 2015, of Meda AB (publ) declared an unchanged dividend of SEK 2.50 per share.

Meda AB Reports Group and Parent Earnings Results for the First Quarter Ended March 31, 2015

Meda AB reported group and parent earnings results for the first quarter ended March 31, 2015. For the quarter, the group's net sales reached SEK 4,583 million against SEK 3,365 million a year ago. Operating profit was SEK 536 million against SEK 462 million a year ago. Net profit was SEK 226 million against SEK 260 million a year ago. Profit attributable to parent company shareholders was SEK 226 million against SEK 260 million a year ago. Basic and diluted earnings per share reached SEK 0.62 against SEK 0.83 a year ago. Cash earnings per share amounted to SEK 0.74 against SEK 1.90 for the same period a year ago. Cash flow from operating activities was SEK 331 million against SEK 615 million a year ago. EBITDA, excluding non-recurring items, was SEK 1,403 million against SEK 1,010 million for the same period a year ago. EBITDA was SEK 1,346 million against SEK 1,010 million for the same period a yea ago. Net debt at March 31, 2015, was SEK 28,949 million against SEK 14,610 million for the same period a year ago. For the quarter, the parent company reported net sales of SEK 1,497 million compared to SEK 11.4 million, operating profit (EBIT) of SEK 131 million compared to SEK 165 million, profit for the period after net financial items (EBT) of SEK 78 million compared to SEK 156 million, net profit of SEK 195 million compared to SEK 11 million for the last year.

Meda AB, Q1 2015 Earnings Call, May 06, 2015

Meda AB, Q1 2015 Earnings Call, May 06, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDAA:SS kr119.50 SEK +4.10

MEDAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.137.70 CHF +0.90
Astellas Pharma Inc ¥1,755 JPY +9.00
H Lundbeck A/S kr135.40 DKK +6.40
Moberg Pharma AB kr63.75 SEK +1.00
Shire PLC 5,210 GBp +115.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MEDAA Industry Range
Price/Earnings 100.0x
Price/Sales 2.7x
Price/Book 2.1x
Price/Cash Flow 120.0x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDA AB-A SHS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at